Repository logo
 

Investigations regarding the utility of prodigiosenes to treat leukemia

Date

2013

Authors

Smithen, Deborah A.
Forrester, A. Michael
Corkery, Dale P.
Dellaire, Graham
Colpitts, Julie
McFarland, Sherri A.
Berman, Jason N.
Thompson, Alison

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Prodigiosenes, possessing a 4-methoxypyrrolyldipyrrin skeleton, are known for their anti-cancer activity. Structural modification of the C-ring resulted in a series of prodigiosenes that displayed promising activity against leukemia cell lines during in vitro analysis against the NCI 60 cancer cell line panel. Further in vivo studies of these compounds using the zebrafish model showed persistence of anti-leukemia properties in human K562 chronic myelogenous leukemia cells.

Description

Keywords

Citation

Smithen, Deborah A., A. Michael Forrester, Dale P. Corkery, Graham Dellaire, et al. 2013. "Investigations regarding the utility of prodigiosenes to treat leukemia." Organic & Biomolecular Chemistry 11(1): 62-68.

Collections